Additionally, we review recent advances towards therapeutic targeting of EREG and AREG in cancer through the development and use of EREG- and AREG-targeted monoclonal antibodies (mAbs) as well as antibody-drug conjugates (ADCs). This evidence concerns the gene EREG and cancer.